The heat-shock protein receptor CD91 is up-regulated in monocytes of HIV-1-infected "true" long-term nonprogressors

Blood

Volumn 101, Issue 10, 2003, Pages 4000-4004

  Stebbing, Justin ^a   Gazzard, Brian ^b   Kim, Louise ^b   Portsmouth, Simon ^b   Wildfire, Adrian ^b   Teo, Ian ^b   Nelson, Mark ^b   Bower, Mark ^b   Gotch, Frances ^b   Shaunak, Sunil ^b   Srivastava, Pramod ^b   Patterson, Steve ^b  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; CD4 ANTIGEN; CD8 ANTIGEN; HEAT SHOCK PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UNCLASSIFIED DRUG; CD91 ANTIGEN, HUMAN; LEUKOCYTE ANTIGEN; PRIMER DNA; VIRUS RNA;

ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MONOCYTE; PRIORITY JOURNAL; VIRUS LOAD; VIRUS REPLICATION; BLOOD; CD4 LYMPHOCYTE COUNT; DENDRITIC CELL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; NUCLEOTIDE SEQUENCE; SURVIVOR; T LYMPHOCYTE; TIME;

ANTIGENS, CD; BASE SEQUENCE; CD4 LYMPHOCYTE COUNT; DENDRITIC CELLS; DISEASE PROGRESSION; DNA PRIMERS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HIV INFECTIONS; HIV-1; HUMANS; MALE; MONOCYTES; RNA, VIRAL; SURVIVORS; T-LYMPHOCYTES; TIME FACTORS; VIRAL LOAD;

EID: 0038603179     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-11-3353     Document Type: Article

References (48)

1. Pantaleo G, Graziosi C, Fauci AS. New concepts in the immunopathogenesis of human immunodeficiency virus infection. N Engl J Med. 1993;328:327-335.
2. Coffin JM. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science. 1995;267:483-489.
3. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature. 1996;384:529-534.
4. Lifson AR, Rutherford GW, Jaffe HW. The natural history of human immunodeficiency virus infection. J Infect Dis. 1988;158:1360-1367.
5. Lifson AR, Hessol NA, Rutherford GW. Progression and clinical outcome of infection due to human immunodeficiency virus. Clin Infect Dis. 1992;14:966-972.
6. Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD. Long-term HIV-1 infection without immunologic progression. AIDS. 1994;8:1123-1128.
7. Pantaleo G, Menzo S, Vaccarezza M, et al. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med. 1995;332:209-216.
8. Dyer WB, Geczy AF, Kent SJ, et al. Lymphoproliferative immune function in the Sydney Blood Bank Cohort, infected with natural nef/long terminal repeat mutants, and in other long-term survivors of transfusion-acquired HIV-1 infection. AIDS. 1997;11:1565-1574.
9. + T-cell repertoire in long-term nonprogressors and its role in the control of viral load and disease activity. Hum Immunol. 2001;62:561-576.
10. Valdez H, Carlson NL, Post AB, et al. HIV long-term non-progressors maintain brisk CD8 T cell responses to other viral antigens. AIDS. 2002;16:1113-1118.
11. Migueles SA, Laborico AC, Shupert WL, et al. HIV-specific CD8(+) T cell proliferation is coupled to perforin expression and is maintained in nonprogressors [abstract]. Nat Immunol. 2001;7:7.
12. Brambilla A, Turchetto L, Gatti A, et al. Defective nef alleles in a cohort of hemophiliacs with progressing and nonprogressing HIV-1 infection. Virology. 1999;259:349-368.
13. Zhang L, Huang Y, Yuan H, Tuttleton S, Ho DD. Genetic characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection. Virology. 1997;228:340-349.
14. Saksena NK, Ge YC, Wang B, et al. An HIV-1-infected long-term non-progressor (LTNP): molecular analysis of HIV-1 strains in the vpr and nef genes. Ann Acad Med Singapore. 1996;25:848-854.
15. Iversen AK, Shpaer EG, Rodrigo AG, et al. Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual. J Virol. 1995;69:5743-5753.
16. Menzo S, Sampaolesi R, Vicenzi E, et al. Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term nonprogressors. AIDS. 1998;12:985-997.
17. Machuca R, Schonning K, Hansen J, Fomsgaard A, Nielsen C. No association of HIV-1 envelope (C2-V3-C3) sequence pattern with long-term nonprogression. J Acquir Immune Defic Syndr. 2000;25:103-108.
18. Fujii S, Obaru K, Matsushita S, et al. Characterization of proviral DNA from an individual with long-term, nonprogressive infection with HIV-1 and nonrecoverable virus. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;15:247-256.
19. Clerici M, Balotta C, Meroni L, et al. Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection. AIDS Res Hum Retroviruses. 1996;12:1053-1061.
20. Stewart GJ, Ashton LJ, Biti RA, et al. Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection; the Australian Long-Term Non-Progressor Study Group. AIDS. 1997;11:1833-1838.
21. Mazzucchelli R, Corvasce S, Violin M, et al. Role of CCR5, CCR2 and SDF-1 gene polymorphisms in a population of HIV-1-infected individuals. J Biol Regul Homeost Agents. 2001;15:265-271.
22. Zhang YJ, Fracasso C, Fiore JR, et al. Augmented serum neutralizing activity against primary human immunodeficiency virus type 1 (HIV-1) isolates in two groups of HIV-1-infected long-term nonprogressors. J Infect Dis. 1997;176:1180-1187.
23. Bodman-Smith MD, Williams I, Johnstone R, Boylston A, Lydyard PM, Zumla A. T cell receptor usage in patients with non-progressing HIV infection. Clin Exp Immunol. 2002;130:115-120.
24. Migueles SA, Sabbaghian MS, Shupert WL, et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci U S A. 2000;97:2709-2714.
25. Liegler TJ, Yonemoto W, Elbeik T, Vittinghoff E, Buchbinder SP, Greene WC. Diminished spontaneous apoptosis in lymphocytes from human immunodeficiency virus-infected long-term nonprogressors. J Infect Dis. 1998;178:669-679.
26. Zhang L, Yu W, He T, et al. Contribution of human α-detensin-1, -2 and -3 to the anti-HIV-1 activity of CD8 antiviral factor. Science. 2002;298:995-1000.
27. Petrucci A, Dorrucci M, Alliegro MB, et al. How many HIV-infected individuals may be defined as long-term nonprogressors? a report from the Italian Seroconversion Study: Italian Seroconversion Study Group (ISS). J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:243-248.
28. Lefrere JJ, Morand-Joubert L, Mariotti M, et al. Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection. Blood. 1997;90:1133-1140.
29. Goedert JJ, O'Brien TR, Hatzakis A, Kostrikis LG, T cell receptor excision circles and HIV-1 2-LTR episomal DNA to predict AIDS in patients not receiving effective therapy. AIDS. 2001;15:2245-2250.
30. Nunnari G, Otero M, Dornadula G, et al. Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without ongoing cellular infections. AIDS. 2002;16:39-45.
31. Sharkey ME, Teo I, Greenough T, et al. Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy. Nat Med. 2000;6:76-81.
32. Teo I, Choi J, Morlese J, Taylor G, Shaunak S, LightCycler qPCR optimisation for low copy number target DNA [abstract]. J Immunol Methods. 2002;270:119.
33. Teo I, Morlese J, Choi J, Shaunak S. Reliable and reproducible LightCycler qPCR for H(V-1 DNA 2-LTR circles. J Immunol Methods. 2002;270:109-118.
34. Pierson TC, Kieffer TL, Ruff CT, Buck C, Gange SJ, Siliciano RF. Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication. J Virol. 2002;76:4138-4144.
35. Srivastava PK, Udono H, Blachere NE, Li Z. Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics. 1994;39:93-98.
36. Banchereau J, Pulendran B, Steinman R, Palucka K. Will the making of plasmacytoid dendritic cells in vitro help unravel their mysteries? J Exp Med. 2000;192:F39-F44.
37. Donaghy H, Pozniak A, Gazzard B, et al. Loss of blood CD 11 c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood. 2001;98:2574-2576.
38. Gurer C, Cimarelli A, Luban J. Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. J Virol. 2002;76:4666-4670.
39. Nassar T, Akkawi S, Bar-Shavit R, et al. Human alpha-defensin regulates smooth muscle cell contraction: a role for low-density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. Blood. 2002;100:4026-4032.
40. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245-252.
41. Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway. Int Immunol. 2000;12:1539-1546.
42. Berwin B, Reed RC, Nicchitta CV. Virally induced lytic cell death elicits the release of immunogenic GRP94/gp96. J Biol Chem. 2001;276:21083-21088.
43. Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol. 2002;2:185-194.
44. Binder RJ, Han DK, Srivastava PK. CD91: a receptor for heat shock protein gp96. Nat Immunol. 2000;1:151-155.
45. Basu S, Binder RJ, Ramalingam T, Srivastava PK. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity. 2001;14:303-313.
46. Kumaraguru U, Rouse RJ, Nair SK, Bruce BD, Rouse BT. Involvement of an ATP-dependent peptide chaperone in cross-presentation after DNA immunization. J Immunol. 2000;165:750-759.
47. Maltseva NV, Zorina RM, Mingaljev NV, Krajushkina NA, Chirikova TS, Zorin NA. Tissue distribution of rat macroglobulins in tumor-bearing rats. Int J Exp Pathol. 1999;80:105-108.
48. Hunter N, Weston KM, Bowem NA. Suppression of experimental allergic encephalomyelitis by alpha 2-macroglobulin. Immunology. 1991;73:58-63.